LD-2 disclosure · 2nd Quarter - Amendment
ABBOTT LABORATORIES
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
8 issuesHealth Issues
Public Law 117-2 The American Rescue Plan Act of 2021. Public Law 116-123 Coronavirus Preparedness & Response Supplemental Appropriations Act of 2020. Public Law 116-136 CARES (Coronavirus Act, Relief, and Economic Security) Act. S. 1508 To provide for the use of emergency use authorization data and real world evidence. S. 3983/H.R. 7084 PATCH Act of 2022 S. 4348 FDASLA Act of 2022 S. 4386/H.R. 8299 A bill to allow for devices with a predetermined change control plan. H.R. 7667 Food and Drug Amendments of 2022. H.R. 7213 Equitable Community Access to Pharmacist Services Act. H.R. 4511 FACTS Act. H.R. 4128 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021. Proposals regarding regulatory policies affected by public health emergencies. Proposals regarding diagnostic and serologic coronavirus testing. Proposals regarding the Medical Device User Fee Act (MDUFA) reauthorization. Proposals related to medical device cybersecurity. Proposals related to PT/INR (Prothrombin Time/International Normalized Ratio) testing. Proposals to advance policies related to effective pain management. Proposals related to the use of coronavirus testing in CLIA-waived settings. Proposals related to digital health technologies and innovations. Proposals related to the advancement, testing, and detection of Traumatic Brain Injury. Proposals related to testing for malaria.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · ANNE DEVLIN · SETH M RADUS · JENNIFER BARBLAN · ROSALYN KUMAR
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Natl Security Council (NSC) · State, Dept of (DOS) · Centers For Disease Control & Prevention (CDC)
Medicare/Medicaid
Proposals related to Medicare coverage of continuous glucose monitors.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · ROSALYN KUMAR
